Yahoo
    NasdaqCM - Nasdaq Real Time Price USD

    ImmuCell Corporation (ICCC)

    10.55 -0.01 (-0.09%)
    As of 11:55:57 AM EST. Market Open.
    Loading Chart for ICCC
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    ImmuCell Announces a 46% Increase in Product Sales in Quarter Three of 2026, Based on Preliminary, Unaudited Sales Results

    ImmuCell Announces a 46% Increase in Product Sales in Quarter Three of 2026, Based on Preliminary, Unaudited Sales Results
    GlobeNewswire 21d ago
    ImmuCell (ICCC) Q2 2026 Earnings Call Transcript

    ImmuCell (ICCC) Q2 2026 Earnings Call Transcript
    Motley Fool 2mo ago
    ImmuCell Corp (ICCC) (Q2 2026) Earnings Call Highlights: Record Net Income and Market Share ...

    ImmuCell Corp (ICCC) (Q2 2026) Earnings Call Highlights: Record Net Income and Market Share ...
    GuruFocus.com 2mo ago
    ImmuCell Q2 Earnings Call Highlights

    ImmuCell Q2 Earnings Call Highlights
    MarketBeat 2mo ago
    ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2026

    ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2026
    GlobeNewswire 2mo ago
    ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2026

    ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2026
    GlobeNewswire 2mo ago
    ImmuCell Posts Strong Preliminary Q2 Sales on U.S. Demand

    ImmuCell Posts Strong Preliminary Q2 Sales on U.S. Demand
    Zacks 3mo ago
    ImmuCell Announces a 12% Increase in Product Sales in Q2 of 2026 and a 21% Increase in the First Six Months of 2026, Based on Preliminary, Unaudited Sales Results

    ImmuCell Announces a 12% Increase in Product Sales in Q2 of 2026 and a 21% Increase in the First Six Months of 2026, Based on Preliminary, Unaudited Sales Results
    GlobeNewswire 3mo ago
    ICCC's Valuation Remains Premium: Is it Worth Overpaying for?

    ICCC's Valuation Remains Premium: Is it Worth Overpaying for?
    Zacks 4mo ago
    ImmuCell Q1 Earnings Rise Y/Y as Sales Climb on Strong Demand

    ImmuCell Q1 Earnings Rise Y/Y as Sales Climb on Strong Demand
    Zacks 5mo ago
    ImmuCell Corp (ICCC) Q1 2026 Earnings Call Highlights: Record Revenue and Strategic Growth

    ImmuCell Corp (ICCC) Q1 2026 Earnings Call Highlights: Record Revenue and Strategic Growth
    GuruFocus.com 5mo ago

    Related Tickers

    Mobilize your Website
    View Site in Mobile | Classic
    Share by: